CD9 and colonic neoplasm: Collectively, we demonstrated that CD9 associated with EVs derived from donor colon cancer cells and present in recipient cells is involved in EV uptake leading to morphological transformation of recipient cells, including the acquisition of aggressive migratory behavior, and that a monovalent Ab directed against this tetraspanin protein can impede its function.